title: Expression of shared idiotypes by paraproteins from patients with monoclonal gammopathy of undetermined significance.
abstract: We have previously demonstrated the expression of shared idiotypes by the paraproteins from approximately one-quarter of patients with multiple myeloma (MM). We have now investigated whether similar cross-reactivity is expressed in the paraproteins of patients with monoclonal gammopathy of undetermined significance (MGUS), using a panel of 32 monoclonal antibodies (MAB) generated against follicular B cell lymphomas. The paraproteins from 76/409 (19%) patients with MGUS reacted with at least one of 23 different anti-idiotypic antibodies used in this study. 18 MABs demonstrated reactivity with more than one patient's paraprotein. Moreover, 10 MABs reacted frequently (with 5-22 paraproteins). Over half (41/76) of the reactive patients' paraproteins reacted with more than one MAB from this panel. This frequency of anti-idiotypic reactivity was similar to that of previously studied patients with myeloma, chronic lymphocytic leukaemia (CLL), and follicular B-cell lymphomas. There was no correlation between specific anti-idiotypic reactivity and the propensity to develop serious disease (MM, macroglobulinaemia, amyloidosis, or other lymphoproliferative disorders) in patients with MGUS. These results suggest that MGUS is derived from cells producing antibodies that are similar to those of other B-cell malignancies and that the pattern of idiotype expression is irrelevant to malignant potential.
authors.affiliation: Wadsworth Cancer Center, Department of Veterans Administration Medical Center, Los Angeles, CA 90073.
authors.forename: C E
authors.initials: CE
authors.lastname: Kampe
authors.forename: S
authors.initials: S
authors.lastname: Hart
authors.forename: R A
authors.initials: RA
authors.lastname: Miller
authors.forename: A
authors.initials: A
authors.lastname: Lichtenstein
authors.forename: R A
authors.initials: RA
authors.lastname: Kyle
authors.forename: J R
authors.initials: JR
authors.lastname: Berenson
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology; D000912:Antibodies, Neoplasm / Q000276:immunology; D003429:Cross Reactions / Q000276:immunology; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000097:blood*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology; D016393:Lymphoma, B-Cell / Q000276:immunology; D008232:Lymphoproliferative Disorders / Q000276:immunology; D009101:Multiple Myeloma / Q000276:immunology; D010265:Paraproteinemias / Q000276:immunology*; D010266:Paraproteins / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D007130:Immunoglobulin Idiotypes; D010266:Paraproteins